Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) EBT Margin (2016 - 2020)

Historic EBT Margin for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to 1242.72%.

  • Forte Biosciences' EBT Margin rose 1910649500.0% to 1242.72% in Q1 2020 from the same period last year, while for Mar 2020 it was 7658.02%, marking a year-over-year increase of 79433500.0%. This contributed to the annual value of 176430.56% for FY2019, which is 1761685500.0% down from last year.
  • According to the latest figures from Q1 2020, Forte Biosciences' EBT Margin is 1242.72%, which was up 1910649500.0% from 117588.89% recorded in Q4 2019.
  • In the past 5 years, Forte Biosciences' EBT Margin registered a high of 1797.8% during Q3 2016, and its lowest value of 215711.11% during Q4 2018.
  • Moreover, its 5-year median value for EBT Margin was 99530.0% (2017), whereas its average is 90129.85%.
  • In the last 5 years, Forte Biosciences' EBT Margin crashed by 2000000000bps in 2019 and then soared by 1910649500bps in 2020.
  • Forte Biosciences' EBT Margin (Quarter) stood at 1620.88% in 2016, then plummeted by -6786bps to 108370.0% in 2017, then tumbled by -99bps to 215711.11% in 2018, then soared by 45bps to 117588.89% in 2019, then skyrocketed by 101bps to 1242.72% in 2020.
  • Its last three reported values are 1242.72% in Q1 2020, 117588.89% for Q4 2019, and 208166.67% during Q3 2019.